Compare American Express Co (AXP) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Express Co vs Novartis AG — how do they compare? American Express Co trades at $341 (market cap $228.84B), while Novartis AG trades at $153.53 (market cap $298.18B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.02%). Which is the better fit depends on your goals.
| AXP | NVS | |
|---|---|---|
Market Cap | $228.84B | $298.18B |
Sector | Financials | Health |
52-Week High | $384.82 | $168.62 |
52-Week Low | $292.27 | $119.31 |
Dividend Yield | 1.12% | 3.02% |
Enterprise Value | — | $339.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Express Co
American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
